• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.63% Nasdaq Down 2.41%

    ImmunoClin Corporation (IMCL)

    -OTC BB
    0.12 0.00(0.00%) Jun 13
    Prev Close:0.12
    Open:0.12
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:1.43216
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.08 - 3.00
    Volume:0
    Avg Vol (3m):7,139
    Market Cap:3.46M
    P/E (ttm):N/A
    EPS (ttm):-0.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):691.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunoclin Corporation provides comprehensive, clinical, and basic science research services to pharmaceutical, biotechnology, and food industries. It is involved in the research and development on products, such as MIRA, an algorithm to analyze t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback